Sandoz Canada launches two easy-to-use products: Salinex(R) Seawater nasal spray for daily care and Ezeva(TM) zinc oxide cream
December 07, 2015 12:51 ET
|
Sandoz Canada
Lire la version française
BOUCHERVILLE, Quebec, Dec. 7, 2015 (GLOBE NEWSWIRE) -- Sandoz Canada announced today the launch of two easy-to-use products: Salinex® Seawater to help reduce...
Sandoz Canada Launches a New Concentration of (T/C)Lorazepam Injection USP
December 02, 2015 19:54 ET
|
Sandoz Canada
Lire la version française
BOUCHERVILLE, Quebec, Dec. 2, 2015 (GLOBE NEWSWIRE) -- Sandoz Canada is pleased to announce the launch of (T/C)Lorazepam Injection USP 2 mg/mL, a new concentration...
Sandoz Canada Launches a New Concentration of T/CLorazepam Injection USP
December 02, 2015 14:19 ET
|
Sandoz Canada
Lire la version française
BOUCHERVILLE, Quebec, Dec. 2, 2015 (GLOBE NEWSWIRE) -- Sandoz Canada is pleased to announce the launch of T/CLorazepam Injection USP 2 mg/mL, a new concentration now...
Sandoz Canada launches new multi-platform application to show real-time availability of its injectable medicines
October 14, 2015 13:28 ET
|
Sandoz Canada
Version française
BOUCHERVILLE, Quebec, Oct. 14, 2015 (GLOBE NEWSWIRE) -- Sandoz Canada, which established a milestone in transparency by providing the first national report on availability...
Sandoz Canada launches PrSandoz(R) Solifenacin on the Canadian market for the treatment of urinary urgency, frequency and incontinence
October 07, 2015 16:41 ET
|
Sandoz Canada
Version française
BOUCHERVILLE, QC, Oct. 7, 2015 (GLOBE NEWSWIRE) -- Sandoz Canada announced today the launch of a new drug on the Canadian market, PrSandoz® Solifenacin (solifenacin...
Sandoz Canada Celebrates Its 10th Anniversary!
September 25, 2015 09:15 ET
|
Sandoz Canada
Lire la version française
BOUCHERVILLE, Quebec, Sept. 25, 2015 (GLOBE NEWSWIRE) -- Sandoz Canada Inc. celebrated its 10th anniversary on September 19 this year with a colourful event in...
Health Canada Approves New Indications for PrOmnitrope(R) (Somatropin), Canada's First Subsequent Entry Biologic (Biosimilar)
September 02, 2015 16:11 ET
|
Sandoz Canada
Click here for the French version.
BOUCHERVILLE, Quebec, Sept. 2, 2015 (GLOBE NEWSWIRE) -- Sandoz Canada Inc., a Novartis company, has received approval from Health Canada for a number of...
Sandoz Canada launches PrAmiodarone Syringe for the treatment of several heart rhythm disorders
August 20, 2015 16:42 ET
|
Sandoz Canada
BOUCHERVILLE, Quebec, Aug. 20, 2015 (GLOBE NEWSWIRE) -- Version française
Sandoz Canada Inc., a Novartis company, continues to innovate with the launch of PrAmiodarone Syringe (PrAmiodarone...